# Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

> **NCT05863351** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 472 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8

## Interventions

- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Stereotactic Ablative Radiotherapy
- **PROCEDURE:** Systemic Therapy

## Key facts

- **NCT ID:** NCT05863351
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-07
- **Primary completion:** 2030-12-01
- **Final completion:** 2037-08-01
- **Target enrollment:** 472 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05863351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05863351, "Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05863351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*